APOPTOSIS OF BLOOD LYMPHOCYTES IN THE PATIENTS WITH AUTOIMMUNE THYROID DISORDERS

Abstract. This article presents results of apoptosis detection among blood lymphocytes from the patients with autoimmune thyroid disorders, i.e., autoimmune thyroiditis (AIT) at euthyroid and hypothyroid stages, and in diffuse toxic goiter (DTG). Contents of CD95+, annexin V­ presenting (apoptotic) cells and TNFα in blood were analyzed. It was shown, that altered regulation of programmed lymphocyte death in autoimmune thyroid disorders is demonstrated by increased content of TNFα and CD95+ lymphocytes, being accompanied by decreased numbers of apoptotic cells in blood. Meanwhile, this pathology is expressed mostly in DTG, while being less significant in AIT at euthyroid stage, than in thyroid hypofunction. Possible mechanisms of the revealed disturbances are discussed. (Med. Immunol., 2008, vol. 10, N 2-3, pp 187-192).

1. Кайдашев И.П., Гжегорчик Я., Сморавска Е., Ковальски М., ДюБаске Л. Проявление резистентности к апоптозу, индуцированному связыванием CD95(FAS) и молекул HLA I и II классов, мононуклеарными клетками периферической крови больных атопической бронхиальной астмой // Иммунология. – 2006. – Т. 26, № 1. – С. 13­18.

2. Шашкова О.А., Руденко И.Я., Пиневич А.А., Волкова А.Р., Дора С.В., Климович В.Б. Исследование аутоантител к тиреоглобулину при лечении аутоиммунного тиреоидита L тироксином // Мед. иммунология. – 2005. – Т. 7, № 5­6. – С. 511­516.

3. Недоспасов С.А. Фактор некроза опухолей и лимфотоксин: молекулярная генетика, регуляция и физиологическая роль // Генетика. – 2003. – Т. 39, № 2. – С. 207­214.

4. Портянко А.С., Черствой Е.Д. Система Fas/FasL и ее значение для регуляции взаимоотношений опухоли и иммнной системы при папиллярном раке щитовидной железы у детей и подростков // Архив патологии. – 2003. – Т. 65, № 4. – С. 18­21.

5. Суханова Г.А., Акбашева О.Е. Апоптоз. – Томск: Изд­во ТПУ, 2006. – 172 с.

6. Фильченков А.А., Степанов Ю.М., Липкин В.М., Кушлинский Н.Е. Участие системы Fas/Fas­лиганд в регуляции гомеостаза и функционировании клеток иммунной системы // Аллергология и иммунология. – 2002. – № 1. – С. 24­35.

7. Barash J., Dushnitzki D., Barak Y., Miron S., Hahn T. Tumor necrosis factor (TNF) alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children // Immunol. Lett. – 2003. – Vol. 88, N 2. – P. 109­112.

8. Budd R. Death receptors couple both cell proliferation and apoptosis // J. Clin. Invest. – 2002. – Vol. 109. – P. 437­450.

9. Fernández V., Tapia G., Varela P., Romanque P., Cartier­Ugarte D., Videla L.A. Thyroid hormone­induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression // Comp. Biochem. Physiol. Toxicol. Pharmacol. – 2006. – Vol. 142. – P. 231­239.

10. Giordano C., Richiusa P., Bagnasco M., Pizzolanti G., Di Blasi F., Sbriglia M.S., Mattina A., Pesce G., Montagna P., Capone F., Misiano G., Scorsone A., Pugliese A., Galluzzo A. Differential regulation of Fas­mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease // Thyroid. – 2001. – Vol. 11. – P. 233­244.

11. Herbein G., O′brein W.A. Tumor necrosis factor (TNF) α and TNF receptors in viral pathogenesis // Proceedings of the Society for Experimental Biology and Medicine. – 2000. – Vol. 223. – P. 241­257.

12. Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H., Taniguchi N. Differential expression of bcl­2 and susceptibility to anti­Fas­mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils // Blood. – 1994. – Vol. 84. – P. 1201­1208.

13. Krammer P. CD95’s deadly mission in the immune system // Nature. – 2000. – Vol. 407. – P. 789­795.

14. Nakkuntod J., Wongsurawat T., Charoenwong ­ se P., Snabboon T., Sridama V., Hirankarn N. Association of TNF­alpha, TNF­beta, IFN­gamma and IL­1Ra gene polymorphisms with Graves’ disease in the Thai population // Asian Pac. J. Allergy Immunol. – 2006. – Vol. 24. – P. 207­211.

15. Papoff G., Cascino I., Eramo A., Starace G., Lynch D.H., Ruberti G. An N­terminal domain shared by Fas/Apo­1 (CD95) soluble variants prevents cell death in vitro // J. Immunol. – 1996. – Vol. 156. – P. 4622­4630.

16. Pekary A.E., Levin S.R., Johnson D.G., Berg L., Hershman J.M. Tumor necrosis factor­alpha (TNF­alpha) and transforming growth factor­beta 1 (TGF­beta1) inhibit the expression and activity of Na/K­ATPase in FRTL­5 rat thyroid cells // J. Interferon Cytokine Res. – 1997. – Vol. 17. – P. 185­195.